Life-long antimicrobial therapy: Where is the evidence?

Jillian Shu Yun Lau, Tony M. Korman, Ian Woolley

Research output: Contribution to journalArticleOtherpeer-review

Abstract

The decision to prescribe long-term or ‘life-long’ antibiotics in patients requires careful consideration by the treating clinician. While several guidelines exist to help assist in this decision, the long-term consequences are yet to be well studied. In this review, we aim to provide a summary of the available evidence for patient populations where long-term antibiotic therapy is currently recommended in clinical practice. We will also discuss the pitfalls of this approach, including medication adverse effects, economic cost and any possible contribution to the emerging epidemic of microbial resistance.

Original languageEnglish
Pages (from-to)2601-2612
Number of pages12
JournalJournal of Antimicrobial Chemotherapy
Volume73
Issue number10
DOIs
Publication statusPublished - 1 Jan 2018

Cite this

@article{1fb08388383f450891edd8575968e889,
title = "Life-long antimicrobial therapy: Where is the evidence?",
abstract = "The decision to prescribe long-term or ‘life-long’ antibiotics in patients requires careful consideration by the treating clinician. While several guidelines exist to help assist in this decision, the long-term consequences are yet to be well studied. In this review, we aim to provide a summary of the available evidence for patient populations where long-term antibiotic therapy is currently recommended in clinical practice. We will also discuss the pitfalls of this approach, including medication adverse effects, economic cost and any possible contribution to the emerging epidemic of microbial resistance.",
author = "Lau, {Jillian Shu Yun} and Korman, {Tony M.} and Ian Woolley",
year = "2018",
month = "1",
day = "1",
doi = "10.1093/jac/dky174",
language = "English",
volume = "73",
pages = "2601--2612",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "10",

}

Life-long antimicrobial therapy : Where is the evidence? / Lau, Jillian Shu Yun; Korman, Tony M.; Woolley, Ian.

In: Journal of Antimicrobial Chemotherapy, Vol. 73, No. 10, 01.01.2018, p. 2601-2612.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Life-long antimicrobial therapy

T2 - Where is the evidence?

AU - Lau, Jillian Shu Yun

AU - Korman, Tony M.

AU - Woolley, Ian

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The decision to prescribe long-term or ‘life-long’ antibiotics in patients requires careful consideration by the treating clinician. While several guidelines exist to help assist in this decision, the long-term consequences are yet to be well studied. In this review, we aim to provide a summary of the available evidence for patient populations where long-term antibiotic therapy is currently recommended in clinical practice. We will also discuss the pitfalls of this approach, including medication adverse effects, economic cost and any possible contribution to the emerging epidemic of microbial resistance.

AB - The decision to prescribe long-term or ‘life-long’ antibiotics in patients requires careful consideration by the treating clinician. While several guidelines exist to help assist in this decision, the long-term consequences are yet to be well studied. In this review, we aim to provide a summary of the available evidence for patient populations where long-term antibiotic therapy is currently recommended in clinical practice. We will also discuss the pitfalls of this approach, including medication adverse effects, economic cost and any possible contribution to the emerging epidemic of microbial resistance.

UR - http://www.scopus.com/inward/record.url?scp=85060239321&partnerID=8YFLogxK

U2 - 10.1093/jac/dky174

DO - 10.1093/jac/dky174

M3 - Article

VL - 73

SP - 2601

EP - 2612

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 10

ER -